This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lemay, J. Articles by deBlois, D. Search for Related Content PubMed PubMed Citation Articles by Lemay, J. Articles by deBlois, D. Social Bookmarking                         What's this?

Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after injury

University of Montreal Hospital (CHUM) Research Center, Montreal, Quebec, Canada

Pavel Hamet

University of Montreal Hospital (CHUM) Research Center, Montreal, Quebec, Canada

Denis deBlois

University of Montreal Hospital (CHUM) Research Center, Montreal, Quebec, Canada, debloisd{at}pharmco.umontreal.ca

Smooth muscle cell (SMC) apoptosis is transiently increased at the onset of the regression of aortic hypertrophy in spontaneously hypertensive rats (SHR) treated with the angiotensin II AT₁ antagonist losartan. We postulated that losartan induction of SMC apoptosis contributes to suppression of neointimal hyperplasia after vascular injury. Losartan or placebo treatment was initiated two days before balloon injury in the SHR aorta. Compared with time-matched placebo, losartan decreased neointimal cross-sectional area at Days 5 and 10 after injury by 50% and 64% respectively, without affecting medial mass. At Day 10, losartan significantly decreased SMC number (by 56%) in the neointima, but not in the media. DNA synthesis was significantly inhibited at Day 5 but not at Day 10. Losartan significantly increased aortic DNA fragmentation by 2.6- and 4.1-fold, at Days 5 and 10, respectively. In situ labeling of SMC with terminal deoxynucleotidyltransferase revealed significant 61% and 68% increases in apoptotic SMC at Days 5 and 10 with losartan treatment, predominantly in the neointima. Thus, losartan suppressed neointima formation in part by the induction of SMC apoptosis, which may be dissociated from the inhibition of DNA synthesis. Therefore, losartan-induced SMC apoptosis may be a potential therapeutic approach to control occlusive vascular disorders.

Key Words: vascular injury;AT1 antagonist • SHR aorta • apoptosis • smooth muscle cell

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 1, 46-50 (2000)
DOI: 10.3317/jraas.2000.010


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?